SB 1688 (2022) -  Pharmaceutical Products Containing Cannabis

General Bill by Gruters
Pharmaceutical Products Containing Cannabis: Excluding cannabis from Schedule I listing if it is contained within a pharmaceutical product approved by the United States Food and Drug Administration, etc.
Effective Date: Upon becoming a law
Last Event: 03/14/22 S Died in Regulated Industries on Monday, March 14, 2022 1:02 PM

Referred Committees and Committee Actions

Senate Referrals

  • Regulated Industries
  • Health Policy
  • Rules

Related Bills

Bill # Subject Relationship
Bill #: HB 1323 Subject: Pharmaceutical Products Containing Cannabis Relationship: Similar

Bill Text

Staff Analysis

(None Available)

Vote History

(No Votes Recorded)

Bill History

Event Time Member Committee Ver.
Event: S Died in Regulated Industries Time: 03/14/2022 - 1:02 PM Member: Committee: Regulated Industries Version: __
Event: S Indefinitely postponed and withdrawn from consideration Time: 03/12/2022 - 12:00 AM Member: Committee: Version: __
Event: S Introduced -SJ 145 Time: 01/18/2022 - 4:22 PM Member: Committee: Version: __
Event: S Referred to Regulated Industries; Health Policy; Rules -SJ 145 Time: 01/12/2022 - 11:32 AM Member: Committee: Regulated Industries Version: __
Event: S Filed Time: 01/06/2022 - 4:54 PM Member: Committee: Version: __

Statutes Referenced by this Bill

Statute Other Bill Citations
893.03 HB 467, HB 549, HB 1323, SB 1884